Literature DB >> 6467572

Delta bilirubin in serum of pediatric patients: correlations with age and disease.

E M Brett, J M Hicks, D M Powers, R N Rand.   

Abstract

At least four bilirubin fractions can be separated and identified by liquid chromatography, the least understood being the "delta" fraction (B delta), which apparently is covalently bound to albumin. To learn more about the incidence and significance of B delta, we assayed serum from 539 infants and children, both by the chromatographic method and the routine colorimetric Jendrassik-Grof method. The proportion of B delta appeared to correlate with both age and disease course. For infants younger than 28 days B delta generally was less than 2% of total bilirubin; for hyperbilirubinemic older infants and children the median B delta value was 35%. High B delta (greater than 50% of total bilirubin) in newborns was associated with intra- and extra-hepatic cholestasis, biliary cirrhosis, biliary atresia, and hepatitis. Among older infants and children, a proportion of low B delta (less than 10%) was found in hemolytic anemias, sepsis, shock, and other non-hepatic jaundice. In several cases, when low B delta was accompanied by increased conjugated bilirubin, the prognosis was very poor. Delayed clearance of B delta from the circulation together with its reactivity in direct diazo methods may interfere with interpretation of values for conjugated bilirubin as measured by classical methods.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467572

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Factors Determining δ-Bilirubin Levels in Infants With Biliary Atresia.

Authors:  Wen Ye; Philip Rosenthal; John C Magee; Peter F Whitington
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-05       Impact factor: 2.839

2.  Limitations and opportunities of whole blood bilirubin measurements by GEM premier 4000®.

Authors:  Li Wang; Arianne Y K Albert; Benjamin Jung; Keyvan Hadad; Martha E Lyon; Melanie Basso
Journal:  BMC Pediatr       Date:  2017-03-29       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.